Pfizer (China)

304 papers and 5.8k indexed citations i.

About

In recent decades, authors affiliated with Pfizer (China) have published 304 papers, which have received a total of 5.8k indexed citations. Scholars at this organization have produced 63 papers in Pulmonary and Respiratory Medicine, 56 papers in Epidemiology and 53 papers in Oncology on the topics of Lung Cancer Treatments and Mutations (26 papers), Chronic Lymphocytic Leukemia Research (22 papers) and Pneumonia and Respiratory Infections (21 papers). Their work is cited by papers focused on Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Rheumatology (1.1k citations). Authors at Pfizer (China) collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Journal of Clinical Oncology and Blood. Some of Pfizer (China)'s most productive authors include Peng Dong, Sajita Setia, Pasi A. Jänne, Yixi Chen and Ian W. Taylor.

In The Last Decade

Fields of papers published by authors at Pfizer (China)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Pfizer (China) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Pfizer (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Pfizer (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pfizer (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pfizer (China) more than expected).

Rankless by CCL
2025